Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Repligen
3198
Repligen
Technology
Biotechnology
Life Sciences
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Suggest edits
Type
B2c
Founded
1981
Raised
$4M
Follow us
Companies in the same industry
Vyome Therapeutics Inc.
Genomics Medicine Ireland
CustoMem
DNA Script
MIP Diagnostics
Elevation Oncology Inc.
Genemod
Benchling
Invenra
Broad Institute
Alexa global traffic share
Twitter followers
Overview
Funding
1
Acquisitions
1
Add info
Latest funding
$4,000,000
Venture capital - 2014
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
MedCity News
Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals
SiliconRepublic
,
Business Plus
Repligen to create 130 new jobs in Waterford site expansion
The Motley Fool
Read This Before You Sell Repligen Corporation Stock
The Motley Fool
Repligen Corporation Jumped 14.6% in February -- Here's Why
The Motley Fool
Why Repligen Corporation Shares Are Falling --
